1000 related articles for article (PubMed ID: 25053660)
21. Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia.
Blom DJ; Cuchel M; Ager M; Phillips H
Orphanet J Rare Dis; 2018 Jun; 13(1):96. PubMed ID: 29925433
[TBL] [Abstract][Full Text] [Related]
22. Homozygous familial hypercholesterolemia in childhood: Genotype-phenotype description, established therapies and perspectives.
Sanna C; Stéphenne X; Revencu N; Smets F; Sassolas A; Di Filippo M; Descamps OS; Sokal EM
Atherosclerosis; 2016 Apr; 247():97-104. PubMed ID: 26894473
[TBL] [Abstract][Full Text] [Related]
23. Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: A retrospective review of 39 pregnancies.
Botha TC; Pilcher GJ; Wolmarans K; Blom DJ; Raal FJ
Atherosclerosis; 2018 Oct; 277():502-507. PubMed ID: 30270091
[TBL] [Abstract][Full Text] [Related]
24. Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN.
Reijman MD; Kusters DM; Groothoff JW; Arbeiter K; Dann EJ; de Boer LM; de Ferranti SD; Gallo A; Greber-Platzer S; Hartz J; Hudgins LC; Ibarretxe D; Kayikcioglu M; Klingel R; Kolovou GD; Oh J; Planken RN; Stefanutti C; Taylan C; Wiegman A; Schmitt CP
Atherosclerosis; 2024 May; 392():117525. PubMed ID: 38598969
[TBL] [Abstract][Full Text] [Related]
25. Case of homozygous familial hypercholesterolaemia with premature coronary artery disease.
Suresh Kumar G; Mathbout MF; Fahsah I; Ghafghazi S
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34011640
[TBL] [Abstract][Full Text] [Related]
26. Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry.
Cuchel M; Lee PC; Hudgins LC; Duell PB; Ahmad Z; Baum SJ; Linton MF; de Ferranti SD; Ballantyne CM; Larry JA; Hemphill LC; Kindt I; Gidding SS; Martin SS; Moriarty PM; Thompson PP; Underberg JA; Guyton JR; Andersen RL; Whellan DJ; Benuck I; Kane JP; Myers K; Howard W; Staszak D; Jamison A; Card MC; Bourbon M; Chora JR; Rader DJ; Knowles JW; Wilemon K; McGowan MP
J Am Heart Assoc; 2023 May; 12(9):e029175. PubMed ID: 37119068
[TBL] [Abstract][Full Text] [Related]
27. Phenotype diversity among patients with homozygous familial hypercholesterolemia: A cohort study.
Raal FJ; Sjouke B; Hovingh GK; Isaac BF
Atherosclerosis; 2016 May; 248():238-44. PubMed ID: 27017151
[TBL] [Abstract][Full Text] [Related]
28. [TREATMENT OF HOMOZYGOTES OF FAMILIAL HYPERCHOLESTEROLEMIA: RECOMMENDATIONS OF THE ISRAELI SOCIETY OF ATHEROSCLEROSIS].
Cohen H; Durst R; Elis A; Gavish D; Schurr D
Harefuah; 2021 Mar; 160(3):170-174. PubMed ID: 33749180
[TBL] [Abstract][Full Text] [Related]
29. Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study).
Waldmann E; Vogt A; Crispin A; Altenhofer J; Riks I; Parhofer KG
Atherosclerosis; 2017 Apr; 259():20-25. PubMed ID: 28279833
[TBL] [Abstract][Full Text] [Related]
30. Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study.
Alonso R; Arroyo-Olivares R; Díaz-Díaz JL; Fuentes-Jiménez F; Arrieta F; de Andrés R; Gonzalez-Bustos P; Argueso R; Martin-Ordiales M; Martinez-Faedo C; Illán F; Saenz P; Donate JM; Sanchez Muñoz-Torrero JF; Martinez-Hervas S; Mata P
Atherosclerosis; 2024 Jun; 393():117516. PubMed ID: 38523000
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of hepatic microsomal triglyceride transfer protein - a novel therapeutic option for treatment of homozygous familial hypercholesterolemia.
Vuorio A; Tikkanen MJ; Kovanen PT
Vasc Health Risk Manag; 2014; 10():263-70. PubMed ID: 24851052
[TBL] [Abstract][Full Text] [Related]
32. Homozygous Familial Hypercholesterolemia (HoFH) in Saudi Arabia and Two Cases of Lomitapide Use in a Real-World Setting.
Mahzari M; Zarif H
Adv Ther; 2021 May; 38(5):2159-2169. PubMed ID: 33829367
[TBL] [Abstract][Full Text] [Related]
33. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
[TBL] [Abstract][Full Text] [Related]
34. A Case Series Assessing the Effects of Lomitapide on Carotid Intima-Media Thickness in Adult Patients with Homozygous Familial Hypercholesterolaemia in a Real-World Setting.
Blom DJ; Gaudet D; Hegele RA; Patel DS; Cegla J; Kolovou G; Marin LM
Adv Ther; 2022 Apr; 39(4):1857-1870. PubMed ID: 35194765
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study.
D'Erasmo L; Steward K; Cefalù AB; Di Costanzo A; Boersma E; Bini S; Arca M; van Lennep JR;
Eur J Prev Cardiol; 2022 May; 29(5):832-841. PubMed ID: 34971394
[TBL] [Abstract][Full Text] [Related]
36. Homozygous familial hypercholesterolemia with severe involvement of the aortic valve-A sibling-controlled case study on the efficacy of lipoprotein apheresis.
Galiano M; Hammersen J; Sauerstein K; Blessing H; Rümmele P; Purbojo A; Schöber M; Moosmann J; Raffelsbauer G; Heibges A; Klingel R
J Clin Apher; 2020 Jun; 35(3):163-171. PubMed ID: 32163632
[TBL] [Abstract][Full Text] [Related]
37. Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey.
D'Erasmo L; Gallo A; Cefalù AB; Di Costanzo A; Saheb S; Giammanco A; Averna M; Buonaiuto A; Iannuzzo G; Fortunato G; Puja A; Montalcini T; Pavanello C; Calabresi L; Vigna GB; Bucci M; Bonomo K; Nota F; Sampietro T; Sbrana F; Suppressa P; Sabbà C; Fimiani F; Cesaro A; Calabrò P; Palmisano S; D'Addato S; Pisciotta L; Bertolini S; Bittar R; Kalmykova O; Béliard S; Carrié A; Arca M; Bruckert E
Orphanet J Rare Dis; 2021 Sep; 16(1):381. PubMed ID: 34496902
[TBL] [Abstract][Full Text] [Related]
38. Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia.
Kolovou G; Diakoumakou O; Kolovou V; Fountas E; Stratakis S; Zacharis E; Liberopoulos EN; Matsouka F; Tsoutsinos A; Mastorakou I; Katsikas T; Mavrogeni S; Hatzigeorgiou G
Eur J Prev Cardiol; 2020 Jan; 27(2):157-165. PubMed ID: 31403880
[TBL] [Abstract][Full Text] [Related]
39. Lomitapide for the management of homozygous familial hypercholesterolemia.
deGoma EM
Rev Cardiovasc Med; 2014; 15(2):109-18. PubMed ID: 25051128
[TBL] [Abstract][Full Text] [Related]
40. Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment.
Raal FJ; Santos RD
Atherosclerosis; 2012 Aug; 223(2):262-8. PubMed ID: 22398274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
